Literature DB >> 15582470

Synthesis and biological relationships of 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents.

Ya-Yun Lai1, Li-Jiau Huang, Kuo-Hsiung Lee, Zhiyan Xiao, Kenneth F Bastow, Takao Yamori, Sheng-Chu Kuo.   

Abstract

As part of a continuing search for potential anticancer drug candidates in the 2-phenyl-4-quinolone series, 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives and their salts were synthesized and evaluated. Preliminary screening showed that carboxylic acid analogs containing a m-fluoro substituted 2-phenyl group displayed the highest in vitro anticancer activity. Activity decreased significantly if a chlorine or methoxy group replaced the fluorine atom. 3'-Fluoro-6-methoxy-2-phenyl-4-quinolone-3-carboxylic acid (68) had the highest in vitro cytotoxic activity among all tested carboxylic acid derivatives and their salts. The mechanism of action may be similar, but not identical, to that of tubulin binding drugs, such as navelbine and taxol. Compound 68 merits further investigation as a novel hydrophilic antimitotic agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582470     DOI: 10.1016/j.bmc.2004.09.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.

Authors:  Yiqun Zhang; Julie A Clark; Michele C Connelly; Fangyi Zhu; Jaeki Min; W Armand Guiguemde; Anupam Pradhan; Lalitha Iyer; Anna Furimsky; Jason Gow; Toufan Parman; Farah El Mazouni; Margaret A Phillips; Dennis E Kyle; Jon Mirsalis; R Kiplin Guy
Journal:  J Med Chem       Date:  2012-04-18       Impact factor: 7.446

2.  Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.

Authors:  Yong Jin Kim; Eun Ae Kim; Mi Lyang Chung; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

3.  Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils.

Authors:  Ya-Ru Tsai; Li-Jiau Huang; Hui-Yi Lin; Yun-Jie Hung; Miau-Rong Lee; Sheng-Chu Kuo; Mei-Feng Hsu; Jih-Pyang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-23       Impact factor: 3.000

4.  Design and synthesis of 2-(3-benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one analogues as potent antitumor agents that inhibit tubulin assembly.

Authors:  Yu-Hsun Chang; Mei-Hua Hsu; Sheng-Hung Wang; Li-Jiau Huang; Keduo Qian; Susan L Morris-Natschke; Ernest Hamel; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

5.  Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead.

Authors:  Yung-Yi Cheng; Chin-Yu Liu; Meng-Tung Tsai; Hui-Yi Lin; Jai-Sing Yang; Tian-Shung Wu; Sheng-Chu Kuo; Li-Jiau Huang; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2013-07-04       Impact factor: 2.823

6.  2,6-Dichloro-N-(4-chloro-phen-yl)benzamide.

Authors:  Jing Zhu; Ming Li; Hong-Xia Wei; Jian-Qiang Wang; Cheng Guo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-24

7.  Cytotoxicity and Structure-activity Relationships of Naphthyridine Derivatives in Human Cervical Cancer, Leukemia, and Prostate Cancer.

Authors:  Yu Jin Hwang; Mi Lyang Chung; Uy Dong Sohn; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2013-12-16       Impact factor: 2.016

8.  Synthesis and antibacterial activity evaluation of N (7) position-modified balofloxacins.

Authors:  Ge Hong; Weitian Li; Lina Mao; Jiawen Wang; Tianjun Liu
Journal:  Front Chem       Date:  2022-08-19       Impact factor: 5.545

9.  Novel N-2-(Furyl)-2-(chlorobenzyloxyimino) Ethyl Piperazinyl Quinolones: Synthesis, Cytotoxic Evaluation and Structure-Activity Relationship.

Authors:  Negar Mohammadhosseini; Mahboobeh Pordeli; Maliheh Safavi; Loghman Firoozpour; Fatame Amin; Sussan Kabudanian Ardestani; Najmeh Edraki; Abbas Shafiee; Alireza Foroumadi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.